These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2820818

  • 1. Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells.
    Tienari J, Virtanen I, Soinila S, Lehtonen E.
    Dev Biol; 1987 Oct; 123(2):566-73. PubMed ID: 2820818
    [Abstract] [Full Text] [Related]

  • 2. Neuronal differentiation in F9 embryonal carcinoma cells.
    Wartiovaara J, Liesi P, Rechardt L.
    Cell Differ; 1984 Dec; 15(2-4):125-8. PubMed ID: 6100170
    [Abstract] [Full Text] [Related]

  • 3. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD, Strewler GJ, King KL, Nissenson RA.
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [Abstract] [Full Text] [Related]

  • 4. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
    Morita A, Kitagawa Y, Sugimoto E.
    J Cell Physiol; 1985 Nov; 125(2):263-72. PubMed ID: 2997239
    [Abstract] [Full Text] [Related]

  • 5. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.
    Damjanov I, Zhu ZM, Andrews PW, Fenderson BA.
    In Vivo; 1994 Nov; 8(6):967-73. PubMed ID: 7772748
    [Abstract] [Full Text] [Related]

  • 6. Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.
    Grover A, Adamson ED.
    In Vitro Cell Dev Biol; 1986 May; 22(5):280-4. PubMed ID: 2423499
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells.
    Imada S, Yamaguchi H, Imada M.
    Dev Biol; 1990 Oct; 141(2):426-30. PubMed ID: 1698671
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells.
    Galvin-Parton PA, Watkins DC, Malbon CC.
    J Biol Chem; 1990 Oct 15; 265(29):17771-9. PubMed ID: 2170395
    [Abstract] [Full Text] [Related]

  • 9. Expression of laminin and fibronectin in endodermal and neural differentiation of F9 embryonal carcinoma cells.
    Wartiovaara J, Liesi P, Rechardt L.
    Prog Clin Biol Res; 1984 Oct 15; 151():233-47. PubMed ID: 6473367
    [No Abstract] [Full Text] [Related]

  • 10. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
    Nagarajan L, Jetten AM, Anderson WB.
    Exp Cell Res; 1983 Sep 15; 147(2):315-27. PubMed ID: 6193979
    [Abstract] [Full Text] [Related]

  • 11. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
    Kohda T, Kondo K, Oishi M.
    FEBS Lett; 1991 Sep 23; 290(1-2):107-10. PubMed ID: 1655528
    [Abstract] [Full Text] [Related]

  • 12. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA, Campisi J, Wang SY, Gudas LJ.
    Dev Biol; 1984 Oct 23; 105(2):443-50. PubMed ID: 6090244
    [Abstract] [Full Text] [Related]

  • 13. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
    Braunhut SJ, Gudas LJ, Kurokawa T, Sasse J, D'Amore PA.
    J Cell Biol; 1989 Jun 23; 108(6):2467-76. PubMed ID: 2544608
    [Abstract] [Full Text] [Related]

  • 14. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene.
    Thompson JR, Gudas LJ.
    Mol Cell Endocrinol; 2002 Sep 30; 195(1-2):119-33. PubMed ID: 12354678
    [Abstract] [Full Text] [Related]

  • 15. Nerve growth factor induces adrenergic neuronal differentiation in F9 teratocarcinoma cells.
    Liesi P, Rechardt L, Wartiovaara J.
    Nature; 2002 Sep 30; 306(5940):265-7. PubMed ID: 6139754
    [Abstract] [Full Text] [Related]

  • 16. Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells.
    Cho Y, Klein MG, Talmage DA.
    Cell Growth Differ; 1998 Feb 30; 9(2):147-54. PubMed ID: 9486851
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
    Khuri FR, Cho Y, Talmage DA.
    Cell Growth Differ; 1996 May 30; 7(5):595-602. PubMed ID: 8732669
    [Abstract] [Full Text] [Related]

  • 18. Lectin binding of F9 embryonal carcinoma cells: evidence for population heterogeneity and developmentally regulated high-Mr cell surface proteins.
    Tienari J, Virtanen I, Lehtonen E.
    J Cell Sci; 1989 Apr 30; 92 ( Pt 4)():561-8. PubMed ID: 2557358
    [Abstract] [Full Text] [Related]

  • 19. Induction of neural-like cells and acetylcholinesterase activity in cultures of F9 teratocarcinoma treated with retinoic acid and dibutyryl cyclic adenosine monophosphate.
    Kuff EL, Fewell JW.
    Dev Biol; 1980 Jun 01; 77(1):103-15. PubMed ID: 6249683
    [No Abstract] [Full Text] [Related]

  • 20. Reversible interconversion between primitive endoderm- and parietal endoderm-like F9 cells demonstrated by mRNAs expression.
    Miki K, Sugimoto E, Kitagawa Y.
    J Biochem; 1987 Aug 01; 102(2):385-92. PubMed ID: 2822687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.